Sudhakar Sridharan is executive medical director of global product development in immunology and rheumatology at PPD. He applies his extensive global drug development and therapeutic medical expertise to create strategic plans and consultive advice to biopharmaceutical and biotech clients to guide their clinical development programs. A board-certified rheumatologist, his career spans both clinical and industry leadership roles in immunology at the Cleveland Clinic, Wyeth Pharmaceuticals, and Pfizer.